What is Supernus Pharmaceuticals's common stock?

Supernus Pharmaceuticals (SUPN) reported common stock of 130M in Q1 2026.

How has Supernus Pharmaceuticals's common stock changed year-over-year?

Supernus Pharmaceuticals's common stock decreased by 0.0% year-over-year, from 130M to 130M.

What is the long-term trend for Supernus Pharmaceuticals's common stock?

Over 5 years (2020 to 2025), Supernus Pharmaceuticals's common stock has grown at a 376.4% compound annual growth rate (CAGR), from 53K to 130M.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Supernus Pharmaceuticals SUPN Common Stock

Common Stock at other companies

AbbVieABBV

$18M0.0%

Rapport Therapeutics, Inc.RAPP

$48K+29.7%

Axsome TherapeuticsAXSM

$5K0.0%

Neurocrine BiosciencesNBIX

220M0.0%

Jazz PharmaceuticalsJAZZ

$0-100%

Acadia PharmaceuticalsACAD

$16K0.0%

Other financials

Income statement

See full

Revenue$207.7M+38.6%

Gross profit$184.3M+37.5%

Operating income-$8.3M+18.8%

Net income-$2.3M+80.6%

EPS (diluted)-$0.04+81.0%

Balance sheet

See full

Cash & equivalents$186.3M+60.8%

Total debt$40.9M+26.6%

Total equity$1.1B+4.5%

Total assets$1.5B+11.4%

Cash flow

See full

Operating cash flow$66.5M+117%

CapEx--100%

Free cash flow$66.5M+120%

Valuation

See full

Market cap$2.58B+62.8%

Enterprise value$2.44B+62.3%

P/S3.3×+0.9×

Profitability

See full

Gross margin89.4%+1.0pp

Operating margin-7.8%-18.9pp

Net margin-3.7%-13.0pp

FCF margin27.9%+3.4pp

Returns & leverage

See full

Return on equity-2.8%-9.1pp

Debt / equity0×0.0×

Current ratio2×-0.5×

Where this comes from

Reported directly by Supernus Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Supernus Pharmaceuticals's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Supernus Pharmaceuticals's common stock?: Supernus Pharmaceuticals (SUPN) reported common stock of 130M in Q1 2026.
How has Supernus Pharmaceuticals's common stock changed year-over-year?: Supernus Pharmaceuticals's common stock decreased by 0.0% year-over-year, from 130M to 130M.
What is the long-term trend for Supernus Pharmaceuticals's common stock?: Over 5 years (2020 to 2025), Supernus Pharmaceuticals's common stock has grown at a 376.4% compound annual growth rate (CAGR), from 53K to 130M.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).